Opendata, web and dolomites

FUSEDESIGN SIGNED

Model-guided design of a stabilized pre-fusion class III viral fusogen, rabies virus glycoprotein

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 FUSEDESIGN project word cloud

Explore the words cloud of the FUSEDESIGN project. It provides you a very rough idea of what is the project "FUSEDESIGN" about.

exposure    kills    position    glycoprotein    health    unusual    departments    billions    combining    translational    antiviral    fusogens    subunit    critical    stabilized    vaccines    academic    data    herpesvirus    reported    certain    mutations    homology    form    structures    equip    rvg    immunologically    biology    vaccinology    generation    costly    notably    quality    clinically    truly    researcher    stabilize    pathogens    stabilise    class    discipline    guided    post    biochemistry    stability    fatal    rabies    conserved    virus    human    cells    computational    cumbersome    centre    structure    guide    expressed    public    mammalian    training    transiently    designed    cutting    immunology    contribution    vaccine    world    forms    candidates    viruses    animals    edge    55    structural    spanning    molecular    trimeric    combination    receptors    fellowship    people    immunogens    neutralizing    fusion    prohibitively    structurally    antibodies    model    herpesviruses    models    interaction    protein    antigenically    glycoproteins    fusogen    stabilization    demand    tractable    mutants    skill    insights    host    interventions    enveloped    mouse   

Project "FUSEDESIGN" data sheet

The following table provides information about the project.

Coordinator
THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD 

Organization address
address: WELLINGTON SQUARE UNIVERSITY OFFICES
city: OXFORD
postcode: OX1 2JD
website: www.ox.ac.uk

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country United Kingdom [UK]
 Total cost 224˙933 €
 EC max contribution 224˙933 € (100%)
 Programme 1. H2020-EU.1.3.2. (Nurturing excellence by means of cross-border and cross-sector mobility)
 Code Call H2020-MSCA-IF-2018
 Funding Scheme MSCA-IF-EF-ST
 Starting year 2019
 Duration (year-month-day) from 2019-07-01   to  2021-06-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD UK (OXFORD) coordinator 224˙933.00

Map

 Project objective

This proposal aims to stabilize the pre-fusion form of rabies virus glycoprotein (RVG), the most structurally-tractable clinically-relevant class III fusogen by combining computational biology, immunology, and structural biology. Rabies virus is fatal; it kills 55,000 people each year and costs billions to control it in animals. Current human rabies vaccines are cumbersome to use and prohibitively costly, thus there is demand for a new generation of rabies vaccines. Enveloped viruses’ fusion glycoproteins are important subunit vaccine candidates. Structure-guided stabilization of class I fusogens has been a major advance in vaccinology. Many major human pathogens have class III fusogens (notably, all herpesviruses and rabies virus): several post-fusion structures have been reported, but their antigenically critical pre-fusion forms have not been stabilized. A high-quality homology model of RVG will guide design of mutations to stabilise the trimeric pre-fusion protein. Designed mutants will be transiently expressed in mammalian cells, selected for stability, and characterized immunologically. Lead candidates will be used as immunogens in mouse models and in structural studies. These data will guide design of improved rabies vaccines, and provide insights into RVG’s interaction with neutralizing antibodies and host receptors. Certain structural elements are conserved across class III fusogens, and so the approach may lead towards stabilization of herpesvirus fusogens. The fellowship will be based between two departments at a world-class host institution. Together, they will offer the Researcher an unusual combination of exposure to both cutting-edge molecular biochemistry and Europe’s leading academic centre for translational vaccine development. This unique training will equip the Researcher with a truly discipline-spanning skill set and position her to make a leading contribution to the development of novel antiviral interventions and public health.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "FUSEDESIGN" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "FUSEDESIGN" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.2.)

ICARUS (2020)

Information Content of locAlisation: fRom classical to qUantum Systems

Read More  

ReSOLeS (2019)

New Reconfigurable Spectrum Optical Fibre Laser Sources

Read More  

EVOMET (2019)

The rise and fall of metastatic clones under immune attack

Read More